Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,359
Views
1
CrossRef citations to date
0
Altmetric
Urology
Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
Jing Voon Chena Medical Decision Modeling, Indianapolis, IN, USACorrespondence[email protected]
https://orcid.org/0000-0003-3632-6806
Timothy M. Kleina Medical Decision Modeling, Indianapolis, IN, USA
, Jeffrey Nesheimb Urovant Sciences, Irvine, CA, USA
https://orcid.org/0000-0003-0805-5615
Paul N. Mudd Jrb Urovant Sciences, Irvine, CA, USA
Pages 1092-1100
|
Received 30 Sep 2021, Accepted 18 Aug 2022, Published online: 09 Sep 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.